[Position paper on the use of drug eluting stents (DES) in percutaneous coronary interventions in patients with coronary heart disease].
Levenson
B
B
Kardiologische Gemeinschaftspraxis, Pestalozzistrasse 38, 10627 Berlin, Germany.
D015906:Angioplasty, Balloon, Coronary / Q000191:economics / Q000295:instrumentation*; D000818:Animals; D020099:Coated Materials, Biocompatible; D023921:Coronary Stenosis / Q000191:economics / Q000628:therapy*; D003362:Cost-Benefit Analysis; D006801:Humans; D017239:Paclitaxel / Q000008:administration & dosage* / Q000191:economics; D016032:Randomized Controlled Trials as Topic; D020123:Sirolimus / Q000008:administration & dosage* / Q000191:economics; D015607:Stents / Q000191:economics
D020099:Coated Materials, Biocompatible; D017239:Paclitaxel; D020123:Sirolimus